Published in J Am Soc Hypertens on April 22, 2010
Aldosterone does not contribute to renal p21 expression during the development of angiotensin II-induced hypertension in mice. Am J Hypertens (2011) 0.79
Chronic angiotensin receptor blockade suppresses intracardiac angiotensin II in angiotensin II-infused rats. Exp Biol Med (Maywood) (2011) 0.77
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med (2000) 18.04
C-reactive protein and the risk of developing hypertension. JAMA (2003) 5.75
Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation (2000) 4.81
Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide. Proc Soc Exp Biol Med (1971) 3.32
Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease. Am J Cardiol (2006) 2.92
Chronic angiotensin II infusion promotes atherogenesis in low density lipoprotein receptor -/- mice. Ann N Y Acad Sci (1999) 2.91
Human C-reactive protein: expression, structure, and function. Mol Immunol (2001) 2.79
C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation (2001) 2.66
Inflammation and angiotensin II. Int J Biochem Cell Biol (2003) 2.22
Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats. Kidney Int (2003) 2.13
Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation (2001) 2.03
C-reactive protein in heart failure: prognostic value and the effect of valsartan. Circulation (2005) 1.92
Spironolactone improves angiotensin-induced vascular changes and oxidative stress. Hypertension (2002) 1.81
Role of oxidative stress in angiotensin-induced hypertension. Am J Physiol Regul Integr Comp Physiol (2003) 1.60
Comparative studies on the binding properties of human and rabbit C-reactive proteins. J Immunol (1980) 1.59
Comparison of interleukin-6 and C-reactive protein for the risk of developing hypertension in women. Hypertension (2006) 1.53
Aldosterone: a mediator of myocardial necrosis and renal arteriopathy. Endocrinology (2000) 1.50
Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats. Hypertension (1998) 1.46
Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart. Endocrinology (2002) 1.45
The novel role of C-reactive protein in cardiovascular disease: risk marker or pathogen. Int J Cardiol (2006) 1.39
Enhanced superoxide generation modulates renal function in ANG II-induced hypertensive rats. Am J Physiol Renal Physiol (2005) 1.27
ANG II-induced cardiac molecular and cellular events: role of aldosterone. Am J Physiol Heart Circ Physiol (2006) 1.23
Systemic and Regional Hemodynamic Responses to Tempol in Angiotensin II-Infused Hypertensive Rats. Hypertension (2001) 1.22
C-reactive protein: a nontraditional serum marker of cardiovascular risk. Cardiovasc Pathol (2007) 1.21
Review of aldosterone- and angiotensin II-induced target organ damage and prevention. Cardiovasc Res (2004) 1.20
C-reactive protein causes downregulation of vascular angiotensin subtype 2 receptors and systolic hypertension in mice. Circulation (2007) 1.19
C-reactive protein: linking inflammation to cardiovascular complications. Circulation (2001) 1.18
Primary structure of human C-reactive protein. Proc Natl Acad Sci U S A (1977) 1.17
Reactive oxygen species-dependent hypertension in dopamine D2 receptor-deficient mice. Hypertension (2006) 1.15
C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases. Med Hypotheses (2004) 1.13
Complement activation in angiotensin II-induced organ damage. Circ Res (2005) 1.13
Aldosterone receptor antagonism exacerbates intrarenal angiotensin II augmentation in ANG II-dependent hypertension. Am J Physiol Renal Physiol (2007) 1.11
C-reactive protein, inflammation, and coronary risk. Med Clin North Am (2000) 1.06
Oxidative stress in hypertension and chronic kidney disease: role of angiotensin II. Semin Nephrol (2004) 1.06
Angiotensin II type 1 receptor blocker telmisartan suppresses superoxide production and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice. Atherosclerosis (2005) 1.06
Eplerenone shows renoprotective effect by reducing LOX-1-mediated adhesion molecule, PKCepsilon-MAPK-p90RSK, and Rho-kinase pathway. Hypertension (2005) 1.04
High-sensitive C-reactive protein, tumor necrosis factor alpha, and cardiovascular risk factors before and after weight loss in obese children. Metabolism (2005) 1.02
Effects of angiotensin II receptor blockade with valsartan on pro-inflammatory cytokines in patients with essential hypertension. J Cardiovasc Pharmacol (2005) 0.99
Eplerenone with valsartan effectively reduces atherosclerotic lesion by attenuation of oxidative stress and inflammation. Arterioscler Thromb Vasc Biol (2006) 0.98
Angiotensin II amplifies macrophage-driven atherosclerosis. Arterioscler Thromb Vasc Biol (2004) 0.95
Role of angiotensin II type 1 receptor in the regulation of cellular adhesion molecules in atherosclerosis. Am Heart J (2001) 0.92
Angiotensin II-induced C-reactive protein generation: inflammatory role of vascular smooth muscle cells in atherosclerosis. Atherosclerosis (2006) 0.90
Angiotensin II administration to atherosclerotic mice increases macrophage uptake of oxidized ldl: a possible role for interleukin-6. Arterioscler Thromb Vasc Biol (2001) 0.88
Eplerenone reduces oxidative stress and enhances eNOS in SHR: vascular functional and structural consequences. Antioxid Redox Signal (2005) 0.87
Significant association of C-reactive protein with arterial stiffness in treated non-diabetic hypertensive patients. Atherosclerosis (2006) 0.82
Effects of eplerenone on heart and kidney in two-kidney, one-clip rats. Am J Nephrol (2003) 0.81
Effect of spironolactone on C-reactive protein levels in patients with heart disease. Int J Cardiol (2006) 0.78
Evidence of fetal C-reactive protein urinary excretion in early gestation. Obstet Gynecol (2003) 0.78
Early markers of inflammation in a high angiotensin II state--results of studies in Bartter's/Gitelman's syndromes. Nephrol Dial Transplant (2006) 0.78
The effect of extended-release metoprolol succinate on C-reactive protein levels in persons with hypertension. J Clin Hypertens (Greenwich) (2006) 0.77
The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev (2007) 6.79
Urinary excretion of angiotensinogen reflects intrarenal angiotensinogen production. Kidney Int (2002) 3.23
Urinary angiotensinogen as an indicator of intrarenal Angiotensin status in hypertension. Hypertension (2003) 2.99
AT1 receptor mediated augmentation of intrarenal angiotensinogen in angiotensin II-dependent hypertension. Hypertension (2004) 2.86
Enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats. Hypertension (2004) 2.54
The absence of intrarenal ACE protects against hypertension. J Clin Invest (2013) 2.31
Ang II accumulation in rat renal endosomes during Ang II-induced hypertension: role of AT(1) receptor. Hypertension (2002) 2.11
Collecting duct renin is upregulated in both kidneys of 2-kidney, 1-clip goldblatt hypertensive rats. Hypertension (2008) 2.01
Novel sandwich ELISA for human angiotensinogen. Am J Physiol Renal Physiol (2007) 1.99
Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients. Hypertension (2008) 1.99
Genetic deletion of AT1a receptors attenuates intracellular accumulation of ANG II in the kidney of AT1a receptor-deficient mice. Am J Physiol Renal Physiol (2007) 1.99
Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on high salt diet. Hypertension (2003) 1.89
Kidney-specific enhancement of ANG II stimulates endogenous intrarenal angiotensinogen in gene-targeted mice. Am J Physiol Renal Physiol (2007) 1.87
AT1 receptor-mediated enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats. Am J Physiol Renal Physiol (2005) 1.84
Enhanced distal nephron sodium reabsorption in chronic angiotensin II-infused mice. Hypertension (2009) 1.83
Sustained renal interstitial macrophage infiltration following chronic angiotensin II infusions. Am J Physiol Renal Physiol (2006) 1.83
Renal interstitial fluid concentrations of angiotensins I and II in anesthetized rats. Hypertension (2002) 1.82
ATP mediates tubuloglomerular feedback. Am J Physiol Regul Integr Comp Physiol (2002) 1.78
Angiotensin II type 1 receptor-mediated augmentation of urinary excretion of endogenous angiotensin II in Val5-angiotensin II-infused rats. Hypertension (2010) 1.67
Intrarenal AT(1) receptor and ACE binding in ANG II-induced hypertensive rats. Am J Physiol Renal Physiol (2002) 1.59
Heme oxygenase induction attenuates afferent arteriolar autoregulatory responses. Am J Physiol Renal Physiol (2008) 1.48
Young Scholars Award Lecture: Intratubular angiotensinogen in hypertension and kidney diseases. Am J Hypertens (2006) 1.46
Augmented cyclooxygenase-2 effects on renal function during varying states of angiotensin II. Am J Physiol Renal Physiol (2010) 1.45
Intracellular ANG II induces cytosolic Ca2+ mobilization by stimulating intracellular AT1 receptors in proximal tubule cells. Am J Physiol Renal Physiol (2005) 1.45
Costimulation with angiotensin II and interleukin 6 augments angiotensinogen expression in cultured human renal proximal tubular cells. Am J Physiol Renal Physiol (2008) 1.37
Determination of plasma and urinary angiotensinogen levels in rodents by newly developed ELISA. Am J Physiol Renal Physiol (2008) 1.34
Augmentation of endogenous intrarenal angiotensin II levels in Val5-ANG II-infused rats. Am J Physiol Renal Physiol (2009) 1.33
Intrarenal mouse renin-angiotensin system during ANG II-induced hypertension and ACE inhibition. Am J Physiol Renal Physiol (2009) 1.30
Increased renin excretion is associated with augmented urinary angiotensin II levels in chronic angiotensin II-infused hypertensive rats. Am J Physiol Renal Physiol (2011) 1.27
Enhanced superoxide generation modulates renal function in ANG II-induced hypertensive rats. Am J Physiol Renal Physiol (2005) 1.27
AT1 receptor-mediated accumulation of extracellular angiotensin II in proximal tubule cells: role of cytoskeleton microtubules and tyrosine phosphatases. Am J Physiol Renal Physiol (2006) 1.27
Angiotensin II stimulates renin in inner medullary collecting duct cells via protein kinase C and independent of epithelial sodium channel and mineralocorticoid receptor activity. Hypertension (2011) 1.25
Renal interstitial fluid angiotensin I and angiotensin II concentrations during local angiotensin-converting enzyme inhibition. J Am Soc Nephrol (2002) 1.24
Angiotensin-converting enzyme-derived angiotensin II formation during angiotensin II-induced hypertension. Hypertension (2008) 1.20
ACE2-mediated reduction of oxidative stress in the central nervous system is associated with improvement of autonomic function. PLoS One (2011) 1.16
Essential role of AT1A receptor in the development of 2K1C hypertension. Hypertension (2002) 1.15
Collecting Duct Renin: A major player in Angiotensin II-dependent Hypertension. J Am Soc Hypertens (2010) 1.14
Involvement of the brain (pro)renin receptor in cardiovascular homeostasis. Circ Res (2010) 1.14
Angiotensin II type 1 receptor-mediated augmentation of renal interstitial fluid angiotensin II in angiotensin II-induced hypertension. J Hypertens (2003) 1.14
Intrarenal angiotensin-converting enzyme induces hypertension in response to angiotensin I infusion. J Am Soc Nephrol (2010) 1.13
Brain-targeted (pro)renin receptor knockdown attenuates angiotensin II-dependent hypertension. Hypertension (2012) 1.12
Pivotal role of angiotensin II receptor subtype 1A in the development of two-kidney, one-clip hypertension: study in angiotensin II receptor subtype 1A knockout mice. J Hypertens (2008) 1.11
Aldosterone receptor antagonism exacerbates intrarenal angiotensin II augmentation in ANG II-dependent hypertension. Am J Physiol Renal Physiol (2007) 1.11
Proximal tubular fluid angiotensin II levels in angiotensin II-induced hypertensive rats. J Hypertens (2003) 1.10
Renal renin-angiotensin system. Contrib Nephrol (2004) 1.09
Cardinal role of the intrarenal renin-angiotensin system in the pathogenesis of diabetic nephropathy. J Investig Med (2013) 1.09
Interferon-γ biphasically regulates angiotensinogen expression via a JAK-STAT pathway and suppressor of cytokine signaling 1 (SOCS1) in renal proximal tubular cells. FASEB J (2012) 1.08
Reciprocal changes in renal ACE/ANG II and ACE2/ANG 1-7 are associated with enhanced collecting duct renin in Goldblatt hypertensive rats. Am J Physiol Renal Physiol (2011) 1.08
Tumor necrosis factor-{alpha} suppresses angiotensinogen expression through formation of a p50/p50 homodimer in human renal proximal tubular cells. Am J Physiol Cell Physiol (2010) 1.06
Natriuretic peptide receptor A mediates renal sodium excretory responses to blood volume expansion. Am J Physiol Renal Physiol (2003) 1.05
Purinergic receptors contribute to early mesangial cell transformation and renal vessel hypertrophy during angiotensin II-induced hypertension. Am J Physiol Renal Physiol (2007) 1.05
High-salt intake enhances superoxide activity in eNOS knockout mice leading to the development of salt sensitivity. Am J Physiol Renal Physiol (2010) 1.03
IL-6 augments angiotensinogen in primary cultured renal proximal tubular cells. Mol Cell Endocrinol (2009) 1.03
Renal nuclear angiotensin II receptors in normal and hypertensive rats. Acta Physiol Hung (2002) 1.01
Intrarenal angiotensin III is the predominant agonist for proximal tubule angiotensin type 2 receptors. Hypertension (2012) 1.00
AT1 receptor-mediated augmentation of angiotensinogen, oxidative stress, and inflammation in ANG II-salt hypertension. Am J Physiol Renal Physiol (2011) 0.99
Interaction between endogenously produced carbon monoxide and nitric oxide in regulation of renal afferent arterioles. Am J Physiol Heart Circ Physiol (2006) 0.99
Salt-induced renal injury in SHRs is mediated by AT1 receptor activation. J Hypertens (2011) 0.98
Calcium and chloride channel activation by angiotensin II-AT1 receptors in preglomerular vascular smooth muscle cells. Am J Physiol Renal Physiol (2005) 0.98
Acute angiotensin II infusions elicit pressure natriuresis in mice and reduce distal fractional sodium reabsorption. Hypertension (2008) 0.97
Activation of the renin-angiotensin system by a low-salt diet does not augment intratubular angiotensinogen and angiotensin II in rats. Am J Physiol Renal Physiol (2013) 0.97
Evolving concepts on regulation and function of renin in distal nephron. Pflugers Arch (2012) 0.94
AT1 receptor blockade prevents the increase in blood pressure and the augmentation of intrarenal ANG II levels in hypertensive Cyp1a1-Ren2 transgenic rats fed with a high-salt diet. Am J Med Sci (2010) 0.94
Divergent localization of angiotensinogen mRNA and protein in proximal tubule segments of normal rat kidney. J Hypertens (2012) 0.92
Afferent arteriolar vasodilator effect of adenosine predominantly involves adenosine A2B receptor activation. Am J Physiol Renal Physiol (2010) 0.91
T-type calcium channels in the regulation of afferent and efferent arterioles in rats. Am J Physiol Renal Physiol (2003) 0.91
Inhibition of fibroblast proliferation in vitro using red light-emitting diodes. Dermatol Surg (2013) 0.90
Nitric oxide synthase inhibition activates L- and T-type Ca2+ channels in afferent and efferent arterioles. Am J Physiol Renal Physiol (2005) 0.89
ANP-mediated inhibition of distal nephron fractional sodium reabsorption in wild-type and mice overexpressing natriuretic peptide receptor. Am J Physiol Renal Physiol (2009) 0.89
Glomerular permeability: a never-ending saga. Am J Physiol Renal Physiol (2009) 0.87
Bilirubin exerts renoprotective effects in angiotensin II-hypertension. Am J Med Sci (2010) 0.87
Contribution of a nuclear factor-kappaB binding site to human angiotensinogen promoter activity in renal proximal tubular cells. Hypertension (2011) 0.87
Renal hemodynamic and excretory responses to intra-arterial infusion of peroxynitrite in anesthetized rats. Am J Physiol Renal Physiol (2008) 0.85
Adenosine A2 receptor activation attenuates afferent arteriolar autoregulation during adenosine receptor saturation in rats. Hypertension (2007) 0.85
Angiotensin II-mediated constriction of afferent and efferent arterioles involves T-type Ca2+ channel activation. Am J Nephrol (2004) 0.84
Nebivolol-induced vasodilation of renal afferent arterioles involves β3-adrenergic receptor and nitric oxide synthase activation. Am J Physiol Renal Physiol (2012) 0.83
Optical coherence tomography (OCT) of collagen in normal skin and skin fibrosis. Arch Dermatol Res (2013) 0.83
The role of microRNAs in skin fibrosis. Arch Dermatol Res (2013) 0.83
The increasing complexity of the intratubular Renin-Angiotensin system. J Am Soc Nephrol (2012) 0.83
Inhibition of heme oxygenase augments tubular sodium reabsorption. Am J Physiol Renal Physiol (2011) 0.83
Renal interstitial fluid ATP responses to arterial pressure and tubuloglomerular feedback activation during calcium channel blockade. Am J Physiol Heart Circ Physiol (2005) 0.82
Human proximal tubular cell responses to angiotensin II analyzed using DNA microarray. Eur J Pharmacol (2003) 0.82
Contribution of renal purinergic receptors to renal vasoconstriction in angiotensin II-induced hypertensive rats. Am J Physiol Renal Physiol (2011) 0.81
Urinary Angiotensinogen as a Novel Biomarker of Intrarenal Renin-Angiotensin System in Chronic Kidney Disease. Int Rev Thromb (2011) 0.80
Angiotensin II-induced reduction in body mass is Ang II receptor mediated in association with elevated corticosterone. Growth Horm IGF Res (2010) 0.80
The complex interplay between cyclooxygenase-2 and angiotensin II in regulating kidney function. Curr Opin Nephrol Hypertens (2012) 0.80
Prorenin receptor in distal nephron segments of 2-kidney, 1-clip goldblatt hypertensive rats. Ochsner J (2013) 0.79
The sodium-activated sodium channel is expressed in the rat kidney thick ascending limb and collecting duct cells and is upregulated during high salt intake. Am J Physiol Renal Physiol (2012) 0.79
Renal heme oxygenase-1 induction with hemin augments renal hemodynamics, renal autoregulation, and excretory function. Int J Hypertens (2012) 0.79
ROCK/NF-κB axis-dependent augmentation of angiotensinogen by angiotensin II in primary-cultured preglomerular vascular smooth muscle cells. Am J Physiol Renal Physiol (2014) 0.79
Attenuated renal vascular responses to acute angiotensin II infusion in smooth muscle-specific Na+/Ca2+ exchanger knockout mice. Am J Physiol Renal Physiol (2011) 0.77
Disruption of Npr1 gene differentially regulates the juxtaglomerular and distal tubular renin levels in null mutant mice. Int J Physiol Pathophysiol Pharmacol (2012) 0.77
Renoprotective effects of direct renin inhibition in glomerulonephritis. Am J Med Sci (2014) 0.76
The legacy of Homer W. Smith: mechanistic insights into renal physiology. J Clin Invest (2004) 0.75
Role of atrial natriuretic peptide in mediating the blood pressure-independent natriuresis elicited by systemic inhibition of nitric oxide. Pflugers Arch (2014) 0.75
Physiology: hemodynamics, endothelial function, renin-angiotensin-aldosterone system, sympathetic nervous system. J Am Soc Hypertens (2014) 0.75
Striae Distensae: Preventative and Therapeutic Modalities to Improve Aesthetic Appearance. Dermatol Surg (2017) 0.75
Successful Treatment of Traumatic Onychodystrophy and Associated Pterygium Unguis With Fractionated Carbon Dioxide Laser: Case Report and Review of the Literature. J Drugs Dermatol (2016) 0.75
In memoriam. Arthur C. Guyton (1919-2003). Physiologist (2003) 0.75
A Systematic Review of Light Emitting Diode (LED) Phototherapy for Treatment of Psoriasis: An Emerging Therapeutic Modality. J Drugs Dermatol (2017) 0.75